HealthEquity Inc. (HQY)
Looking for a Growth Stock? 3 Reasons Why HealthEquity (HQY) is a Solid Choice
HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.
Wall Street Analysts Think HealthEquity (HQY) Could Surge 32.88%: Read This Before Placing a Bet
The mean of analysts' price targets for HealthEquity (HQY) points to a 32.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Here's Why HealthEquity (HQY) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HQY vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of HealthEquity (HQY) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.
Wall Street Analysts Believe HealthEquity (HQY) Could Rally 36.59%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in HealthEquity (HQY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HealthEquity Stock May Gain From Its Latest Partnership With Paytient
HQY collaborates with Paytient to enhance employees' access to healthcare through Health Payment Accounts.
HealthEquity Stock Rises on Q2 Earnings and Revenue Beat
HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.
HealthEquity, Inc. (HQY) Q2 2025 Earnings Call Transcript
HealthEquity, Inc. (NASDAQ:HQY ) Q2 2025 Earnings Conference Call September 3, 2024 4:30 PM ET Company Participants Richard Putnam - IR Jon Kessler - President & CEO James Lucania - EVP & CFO Steve Neeleman - Vice Chair and Founder Conference Call Participants Anne Samuel - J.P. Morgan Glen Santangelo - Jefferies Sean Dodge - RBC Capital Markets Stan Berenshteyn - Wells Fargo Securities Allen Lutz - Bank of America Scott Schoenhaus - KeyBanc David Larsen - BTIG Stephanie Davis - Barclays Mark Marcon - Baird George Hill - Deutsche Bank Operator Good afternoon and welcome to the HealthEquity Second Quarter 2025 Earnings Conference Call.
HealthEquity (HQY) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended July 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
